National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Open Posted
- Opportunity number
- PAR-25-081
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $499,999
Opportunity facts
- Assistance listings
-
- 93.395 Cancer Treatment Research
- 93.394 Cancer Detection and Diagnosis Research
- 93.399 Cancer Control
- 93.393 Cancer Cause and Prevention Research
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- For Profit Organizations
- Tribal Organizations (Not Federally Recognized)
- County Governments
- City/Township Governments
- Non-501(c)(3) Nonprofits
- State Governments
- 501(c)(3) Nonprofits
- Other
- Independent School Districts
- Special District Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- Small Businesses
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute seeks investigator-initiated early phase (Phase 0, I, and II) clinical trial applications addressing cancer-targeted diagnostic and therapeutic interventions with a due date of January 7, 2027. At least one clinical trial must align with the scientific interests of the Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose a standalone early phase trial or combine it with additional research aims.
Eligible applicants include for-profit organizations, tribal governments (federally and non-federally recognized), county and city/township governments, state governments, 501(c)(3) and non-501(c)(3) nonprofits, public and private higher education institutions, special district governments, public housing authorities, independent school districts, and other entity types. Additional eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, faith-based and community-based organizations, Hispanic-serving institutions, historically black colleges and universities, tribally controlled colleges and universities, federal agencies, regional organizations, and non-U.S. entities. The source does not specify award ceiling, award floor, expected number of awards, period of performance, place of performance, cost share requirements, evaluation criteria weighting, or incumbent recipient information.
The opportunity operates under CFDA numbers 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), 93.393 (Cancer Cause and Prevention Research), and 93.399 (Cancer Control). The R01 mechanism is the specified grant instrument, administered by the National Institutes of Health on behalf of NCI's Division of Cancer Treatment and Diagnosis and Office of HIV and AIDS Malignancy.
Synopsis
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-081-Full-Announcement.html | HTML file | |
| PKG00288692.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity